Posts Tagged ‘how much does it cost enbrel europe’

postheadericon Aarkstore-Adalimumab – Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Adalimumab
Adalimumab indications: Rheumatoid arthritis; polyarticular juvenile idiopathic arthritis; psoriatic arthritis; ankylosing spondylitis; Crohn’s disease and plaque psoriasis
Adalimumab innovator: Abbott (Humira)

Examples of information found in this online report include:
# Includes key patent publications for 44 countries (see list below)
# Contains SPC protection for every EU state plus patent term extensions in other countries
# Data exclusivity calculated on a country by country basis
# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
# DMF & Paragraph IV filings
# Litigation alerts
# Marketing authorisation holders in selected territories
# Patent risk analysis via graphical display of data from patent filings
# Hyper-linking to crucial patent documents and national registries enabling data verification

The ‘Key Patent Indicator’ enables easy identification of key patent, SPC and data protection expiry information covering 44 countries, including extension details (SPC and national law) for 30 European countries, Australia, Israel, Japan and the USA. (also available with 44 country coverage):

Pipeline Selector 44 Country Coverage:

Country Region Extensions
Australia Asia-Pacific S70
Canada Americas N/A
USA Americas S156
Germany Western Europe SPC
Great Britain Western Europe SPCS
France Western Europe NAT/SPC
Spain Western Europe SPC
South Africa Africa N/A
China Asia-Pacific N/A
Japan Asia-Pacific S67
New Zealand Asia-Pacific N/A
Bosnia & Herzegovina Balkan N/A
Bulgaria Balkan SPC
Croatia Balkan N/A
Romania Balkan SPC
Slovenia Balkan NAT/SPC
Estonia Baltic NAT/SPC
Lithuania Baltic NAT/SPC
Latvia Baltic NAT/SPC
Czech Republic Central Europe NAT/SPC
Hungary Central Europe SPC
Poland Central Europe SPC
Slovakia Central Europe NAT/SPC
Serbia & Montenegro Central Europe N/A
Cyprus Mediterranean NAT/SPC
Greece Mediterranean SPC
Israel Mediterranean NAT
Malta Mediterranean SPC
Turkey Mediterranean N/A
Denmark Scandinavia SPC
Finland Scandinavia SPC
Iceland Scandinavia SPC
Norway Scandinavia SPC
Sweden Scandinavia SPC
Brazil South America N/A
Mexico South America N/A
Austria Western Europe SPC
Belgium Western Europe SPC
Switzerland Western Europe NAT/SPC
Ireland Western Europe SPC
Italy Western Europe NAT/SPC
Luxembourg Western Europe SPC
The Netherlands Western Europe SPC
Portugal Western Europe SPC

For more information, please contact :
http://www.aarkstore.com/reports/Adalimumab-Key-patent-SPC-and-data-exclusivity-expiry-44-country-coverage–91047.html

 

Incoming search terms:

  • humira in mexico
  • ankylosing spondylitis forum
  • humira cost in mexico
  • buy humira in mexico
  • is humira available in india
  • ankylosis europe scandinavia
  • Can u buy humira in mexico
  • remicade for ankylosing spondylitis and uveitis
  • cost of humira in india
  • enbrel in turkey